Panzem 2-methoxyestradiol regulatory update

FDA granted Orphan Drug designation to Panzem 2ME2 to treat ovarian cancer. The naturally occurring estrogen metabolite also has Orphan Drug designation in the U.S. to treat multiple myeloma (MM). ...